medigraphic.com
Instituto Nacional de Salud Pública

2014, Número 5

<< Anterior Siguiente >>

salud publica mex 2014; 56 (5)


Cáncer de mama en América Latina: carga, patrones y factores de riesgo

Amadou A, Torres-Mejía G, Hainaut P, Romieu I

Idioma: Ingles.
Referencias bibliográficas: 77
Paginas: 547-554
Archivo PDF: 198.70 Kb.


RESUMEN

El cáncer de mama (CaMa) es uno de los mayores problemas de salud pública en América Latina (AL) y el cáncer más frecuente en mujeres. Se observa una importante variabilidad en la incidencia/mortalidad, las características clínicas y el pronóstico según la etnia/raza a lo largo de AL. Además, las mujeres latinoamericanas son más propensas a desarrollar CaMa en edades más tempranas y a ser diagnosticadas en una etapa más avanzada, comparando con mujeres occidentales. Aunque poco se sabe sobre sus factores de riesgo específicos, cambios en los patrones reproductivos (paridad y lactancia) y estilos de vida, incluyendo los hábitos sedentarios, las dietas poco saludables y el consumo de alcohol, podrían contribuir al incremento de la incidencia del CaMa. En este artículo se da una visión general de la carga y los patrones del CaMa, se revisan las causas principales del CaMa y se discuten posibles vías para mejorar la prevención y el control del CaMa en AL.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Bank.World Development Indicators 2010, DC, 2010 [consulted april 2013]. Available from: http://data.worldbank.org/data-catalog/ world-developmentent- indicators/wdi-2010. 04/2013.

  2. WHO, PAHO. Health in the Americas, 2012 edn. Regional oulook and country profiles. Washington, DC: Pan American Health Organization, 2012.

  3. Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri- Guerra Y, St LJ, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol 2013;14:391-436.

  4. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011;378:1461-1484.

  5. Ferlay J, Forman D, Mathers CD, Bray F. Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet 2012;379:1390-1391.

  6. Siegel R, Naishadham D, Jemal. A Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 2012;62:283-298.

  7. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.

  8. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011;61:409-418.

  9. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005;97:439-448.

  10. Sweeney C, Giuliano AR, Baumgartner KB, Byers T, Herrick JS, Edwards SL, et al. Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer 2007;121:2517-2523

  11. Justo N, Wilking N, Jonsson B, Luciani S, Cazap E. A review of breast cancer care and outcomes in Latin America. Oncologist 2013;18:248-256.

  12. Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss. PE Breast cancer in Brazil: present status and future goals. Lancet Oncol 2012;13:e95-e102.

  13. Breen N, Cronin A, Meissner HI, Taplin SH, Tangka FK, Tiro JA, et al. Reported drop in mammography: is this cause for concern? Cancer 2007;109:2405-2409.

  14. Press R, Carrasquillo O, Sciacca RR, Giardina EG. Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Womens Health (Larchmt )2008;17:923-930.

  15. Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN. Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf 2011;37:568-575.

  16. Knaul FM, Wong R, Arreola-Ornelas H, Mendez O. Household catastrophic health expenditures: a comparative analysis of twelve Latin American and Caribbean Countries. Salud Publica Mex 2011;53 suppl 2:s85-s95.

  17. Globocan, IARC, 2010

  18. Coleman MP, Quaresma M, Berrino F, Lutz JM, De AR, Capocaccia R, et al .Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730-756.

  19. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-991.

  20. Puschel K, Coronado G, Soto G, Gonzalez K, Martinez J, Holte S, et al. Strategies for increasing mammography screening in primary care in Chile: results of a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010;19:2254-2261.

  21. Trufelli DC, Miranda VC, Santos MB, Fraile NM, Pecoroni PG, Gonzaga SF, et al. [Analysis of delays in diagnosis and treatment of breast cancer patients at a public hospital]. Rev Assoc Med Bras 2008;54:72-76.

  22. Unger-Saldana K, Pelaez-Ballestas I, Infante-Castaneda C. Development and validation of a questionnaire to assess delay in treatment for breast cancer. BMC Cancer 2012;12:626.

  23. Bright K, Barghash M, Donach M, de la Barrera MG, Schneider RJ, Formenti SC.The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico. Breast 2011;20 suppl 2:S54-S59.

  24. Rezende MC, Koch HA, Figueiredo JA, Thuler LC. [Factors leading to delay in obtaining definitive diagnosis of suspicious lesions for breast cancer in a dedicated health unit in Rio de Janeiro]. Rev Bras Ginecol Obstet 2009;31:75-81.

  25. Gage JC, Ferreccio C, Gonzales M, Arroyo R, Huivin M, Robles SC. Follow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev 2003;27:466-471.

  26. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999;79:858-864.

  27. Knaul F, Bustreo F, Ha E, Langer A. Breast cancer: why link early detection to reproductive health interventions in developing countries? Salud Publica Mex 2009;51 suppl 2:s220-s227.

  28. Robles-Castillo J, Ruvalcaba-Limon E, Maffuz A, Rodriguez-Cuevas S. [Breast cancer in Mexican women under 40]. Ginecol Obstet Mex 2011;79:482-488.

  29. Robles SC, Galanis E. Breast cancer in Latin America and the Caribbean. Rev Panam Salud Publica 2002;11:178-185.

  30. Rodriguez AO, Llacuachaqui M, Pardo GG, Royer R, Larson G, Weitzel JN, et al. BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia. Gynecol Oncol 2012;124:236-243.

  31. Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D, Blake-Cerda M, Arce C, Motola-Kuba D, et al. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 2011;117:3658-3669.

  32. Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752.

  33. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A 2001;98:11462-11467.

  34. Amirikia KC, Mills P, Bush J, Newman LA. Higher population-based incidence rates of triple-negative breast cancer among young African- American women: Implications for breast cancer screening recommendations. Cancer 2011;117:2747-2753.

  35. Boyle P. Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol 2012;23 suppl 6:vi7-vi12.

  36. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009;27:4515-4521.

  37. Olopade OI, Grushko TA, Nanda R, Huo D. Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res 2008;14:7988-7999.

  38. Torres-Mejia G, Angeles-Llerenas A. [Reproductive factors and breast cancer: principal findings in Latin America and the world]. Salud Publica Mex 2009;51 suppl 2:s165-s171.

  39. Gomes AL, Guimaraes MD, Gomes CC, Chaves IG, Gobbi H, Camargos AF. A case-control study of risk factors for breast cancer in Brazil, 1978-1987. Int J Epidemiol 1995;24:292-299.

  40. Tessaro S, Beria JU, Tomasi E, Victora CG. Breastfeeding and breast cancer: a case-control study in Southern Brazil. Cad Saude Publica 2003;19:1593-1601.

  41. Romieu I, Hernandez-Avila M, Lazcano E, Lopez L, Romero-Jaime R. Breast cancer and lactation history in Mexican women. Am J Epidemiol 1996;143:543-552.

  42. Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, El GF. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncol 2005;6:552-553.

  43. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monogr Eval Carcinog Risks Hum 2007;91:1-528.

  44. Sanchez-Zamorano LM, Flores-Luna L, Ángeles-Llerenas A, Romieu I, Lazcano-Ponce E, Miranda-Hernandez H, et al. Healthy lifestyle on the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:912-922.

  45. Lajous M, Willett W, Lazcano-Ponce E, Sanchez-Zamorano LM, Hernandez-Avila M, Romieu I. Glycemic load, glycemic index, and the risk of breast cancer among Mexican women. Cancer Causes Control 2005;16:1165-1169.

  46. Lajous M, Lazcano-Ponce E, Hernandez-Avila M, Willett W, Romieu I. Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 2006;15:443-448.

  47. Romieu I, Lajous M. The role of obesity, physical activity and dietary factors on the risk for breast cancer: Mexican experience. Salud Publica Mex 2009;51 suppl 2:s172-s180.

  48. Romieu I. Diet and breast cancer. Salud Publica Mex 2011;53:430-439.

  49. Romieu I, Lazcano-Ponce E, Sanchez-Zamorano LM, Willett W, Hernandez-Avila M. Carbohydrates and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 2004;13:1283-1289.

  50. De SE, Ronco A, Mendilaharsu M, Guidobono M, eo-Pellegrini H. Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 1997;6:573-581.

  51. Ronco A, De SE, Mendilaharsu M, eo-Pellegrini H. Meat, fat and risk of breast cancer: a case-control study from Uruguay. Int J Cancer 1996;65:328-331.

  52. Chajes V, Torres-Mejia G, Biessy C, Ortega-Olvera C, Ángeles- Llerenas A, Ferrari P, et al. Omega-3 and omega-6 Polyunsaturated fatty acid intakes and the risk of breast cancer in Mexican women: impact of obesity status. Cancer Epidemiol Biomarkers Prev 2012;21:319-326.

  53. Fedirko V, Torres-Mejia G, Ortega-Olvera C, Biessy C, Ángeles- Llerenas A, Lazcano-Ponce E, et al. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control 2012;23:1149-1162.

  54. Pratt M. Physical activity and health in the European Union. Soz Praventivmed 2004;49:297-298.

  55. John EM, Horn-Ross PL, Koo J. Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev 2003;12:1143-1152.

  56. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-S504.

  57. Angeles-Llerenas A, Ortega-Olvera C, Pérez-Rodríguez E, Esparza- Cano JP, Lazcano-Ponce E, Romieu I, et al. Moderate physical activity and breast cancer risk: the effect of menopausal status. Cancer Causes Control 2010;21:577-586.

  58. Baan R, Straif K, Grosse Y, Secretan B, El GF, Bouvard V, et al .Carcinogenicity of alcoholic beverages. Lancet Oncol 2007;8:292-293.

  59. Beasley JM, Coronado GD, Livaudais J, Angeles-Llerenas A, Ortega- Olvera C, Romieu I, et al . Alcohol and risk of breast cancer in Mexican women. Cancer Causes Control 2010;21:863-870.

  60. Muller F, Wehbe L. Smoking and smoking cessation in Latin America: a review of the current situation and available treatments. Int J Chron Obstruct Pulmon Dis 2008;3:285-293.

  61. Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al.Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev 2013;14:665-678.

  62. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.

  63. John EM, Sangaramoorthy M, Phipps AI, Koo J, Horn-Ross PL. Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study. Am J Epidemiol 2011;173:201-216.

  64. Sarkissyan M, Wu Y, Vadgama JV. Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles. Cancer 2011;117:3814-3823.

  65. Sexton KR, Franzini L, Day RS, Brewster A, Vernon SW, Bondy ML. A review of body size and breast cancer risk in Hispanic and African American women. Cancer 2011;117:5271-5281.

  66. Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, et al.Common genetic variants and modification of penetrance of BRCA2- associated breast cancer. PLoS Genet 2010);6: e1001183.

  67. Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK. Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Dtsch Arztebl Int 2011;108:323-330.

  68. Donenberg T, Lunn J, Curling D, Turnquest T, Krill-Jackson E, Royer R, et al.A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. Breast Cancer Res Treat 2011;125:591-596.

  69. Gutierrez-Espeleta GA, Llacuachaqui M, Garcia-Jimenez L, Aguilar HM, Loaiciga VK, Ortiz A,et al. BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica. Clin Genet 2012;82:484-488.

  70. Jara L, Ampuero S, Santibanez E, Seccia L, Rodriguez J, Bustamante M, et al.BRCA1 and BRCA2 mutations in a South American population. Cancer Genet Cytogenet 2006;166:36-45.

  71. Vidal-Millan S, Taja-Chayeb L, Gutierrez-Hernandez O, Ramirez- Ugalde MT, Robles-Vidal C, Bargallo-Rocha E, et al. Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients. Eur J Gynaecol Oncol 2009;30:527-530.

  72. Dufloth RM, Carvalho S, Heinrich JK, Shinzato JY, dos Santos CC, Zeferino LC, et al. Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history. Sao Paulo Med J 2005;123:192-197.

  73. Garcia-Jimenez L, Gutierrez-Espeleta G, Narod SA. [Descriptive epidemiology and molecular genetics of hereditary breast cancer in Costa Rica]. Rev Biol Trop 2012;60:1663-1668.

  74. Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, et al. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. Breast Cancer Res Treat 2006;95:81-87.

  75. Ruiz-Flores P, Sinilnikova OM, Badzioch M, Calderon-Garciduenas AL, Chopin S, Fabrice O, et al. BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico. Hum Mutat 2002;20:474-475.

  76. Vaca-Paniagua F, Álvarez-Gomez RM, Fragoso-Ontiveros V, Vidal- Millan S, Herrera LA, Cantu D, et al. Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer. PLoS One 2012;7:e37432.

  77. Ronco AL, De SE, eo-Pellegrini H. Risk factors for premenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev 2012;13:2879-2886.




2020     |     www.medigraphic.com